EuroAsia RND — Research & DevelopmentRNDResearch & Development Enquiry 0

Dinaciclib

CDK1/2/5/9 Inhibitor

CAS
779353-01-4
Formula
C21H28N6O2
Mol. weight
396.49 g/mol
Purity
≥99%

Price on request. CoA, HPLC, NMR and SDS available on request. For Research Use Only. Not for human or veterinary use.

2D structure of Dinaciclib
Structure from PubChem CID 46926350

Dinaciclib is a potent pan-CDK inhibitor with sub-nanomolar activity against CDK1, 2, 5, and 9. Unlike selective CDK4/6 inhibitors, it induces apoptosis rather than cytostasis by disrupting both cell cycle progression and transcriptional elongation (via CDK9/P-TEFb). Extensively studied in preclinical haematological and solid tumour models.

Target class: CDK inhibitors
Research areas: Breast Cancer, Leukemia, Lung Cancer

Related compounds

SMILESCCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO
InChIKeyPIMQWRZWLQKKBJ-SFHVURJKSA-N